Original Publication Date: 1 December, 2015
Publication / Source: International Journal of Hematologic Oncology
Authors: Maria Ciccone & Alessandra Ferrajoli
Chronic lymphocytic leukemia (CLL) is most commonly diagnosed in patients older than 65 years. Although CLL is commonly believed to be indolent in elderly patients, several studies have shown that CLL reduces life expectancy. In elderly patients who need treatment for CLL, evaluation of disease-specific risk factors should be accompanied by measurement of fitness status and co-morbidities so that a treatment option can be selected that best fits the individual patient’s goals of therapy.